Attached files
| file | filename |
|---|---|
| 10-Q - PROGENICS FORM 10-Q 09/30/2012 - PROGENICS PHARMACEUTICALS INC | form10_q09302012.htm |
| EXCEL - IDEA: XBRL DOCUMENT - PROGENICS PHARMACEUTICALS INC | Financial_Report.xls |
| EX-32 - PROGENICS EXHIBIT 32 09/30/2012 - PROGENICS PHARMACEUTICALS INC | ex3209302012.htm |
| EX-31.1 - PROGENICS EXHIBIT 31.1 09/30/2012 - PROGENICS PHARMACEUTICALS INC | ex31_109302012.htm |
| EX-31.2 - PROGENICS EXHIBIT 31.2 09/30/2012 - PROGENICS PHARMACEUTICALS INC | ex31_209302012.htm |
Exhibit 12.1
Progenics Pharmaceuticals, Inc.
Ratio of Earnings (Loss) to Combined Fixed Charges and Preferred Stock Dividends
(in thousands)
|
|
Nine Months
Ended September 30, |
Years Ended December 31,
|
||||||||||||||||||||||
|
|
2012
|
2011
|
2010
|
2009
|
2008
|
2007
|
||||||||||||||||||
|
Determination of earnings (loss):
|
||||||||||||||||||||||||
|
(Loss) income from operations
|
$
|
(35,107
|
)
|
$
|
10,381
|
$
|
(69,820
|
)
|
$
|
(30,612
|
)
|
$
|
(44,672
|
)
|
$
|
(43,688
|
)
|
|||||||
|
Add:
|
||||||||||||||||||||||||
|
Fixed charges
|
282
|
695
|
709
|
555
|
594
|
483
|
||||||||||||||||||
|
|
||||||||||||||||||||||||
|
Earnings (loss), as adjusted
|
$
|
(34,825
|
)
|
$
|
11,076
|
$
|
(69,111
|
)
|
$
|
(30,057
|
)
|
$
|
(44,078
|
)
|
$
|
(43,205
|
)
|
|||||||
|
|
||||||||||||||||||||||||
|
Fixed charges:
|
||||||||||||||||||||||||
|
|
||||||||||||||||||||||||
|
Estimate of interest within rental expense
|
282
|
695
|
709
|
555
|
594
|
483
|
||||||||||||||||||
|
|
||||||||||||||||||||||||
|
Fixed charges
|
$
|
282
|
$
|
695
|
$
|
709
|
$
|
555
|
$
|
594
|
$
|
483
|
||||||||||||
|
|
||||||||||||||||||||||||
|
Preferred stock dividends
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
-
|
||||||||||||
|
|
||||||||||||||||||||||||
|
|
||||||||||||||||||||||||
|
Ratio of earnings (loss) to fixed charges and preferred stock dividends
|
*
|
16
|
*
|
*
|
*
|
*
|
||||||||||||||||||
|
Coverage deficiency amount for total fixed charges and preferred stock dividends (1)
|
$
|
35,107
|
$
|
-
|
$
|
69,820
|
$
|
30,612
|
$
|
44,672
|
$
|
43,688
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
For the years ended 2007 through 2010 and for the nine months ended September 30, 2012, the Company's coverage ratio is less than one-to-one and it must generate additional earnings of these specified amounts to achieve a coverage ratio of 1:1.
|
|
||||||||||||||||||